Skip to Main Content

Paper Details

NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer.
bioRxiv
0
2023
AR, CRISPR, CRPC, CRPC-, CRPC-NE, CRPC-NE organoids, Cas9, EZH2, H3K27me3, H3K36me2, Human, NE, NEPC tumors, NSD2, Nuclear Receptor Binding SET Domain Protein 2, androgen, androgen receptor, dominant-negative oncohistone H3, enzalutamide, histone H3, human, lysine, mCRPC, metastatic castration-resistant prostate cancer, mice, mouse, neuroendocrine phenotypes, neuroendocrine prostate cancer, neuroendocrine states, organoid lines

Datasets

Release 1.2